The Solution
Thermimage has developed and patented an alternative to the current diagnosis of VUR. Thermimage’s device will provide a non-invasive, safe, reliable, comfortable and cost effective imaging test for detecting pediatric VUR. The new device will eliminate a majority of the VCUG and nuclear cystogram procedures used to detect VUR, increase the detection rate, reduce the usage of unnecessary antibiotics, and help prevent potentially devastating health consequences later in life.
The Thermaflux Scan™ is a safe, non-traumatic, non-invasive procedure that, unlike current procedures, does not require catheterization or expose the child to harmful radiation or contrast agents to diagnose pediatric VUR. Performed externally, the process warms the bladder contents and monitors the kidney temperatures to reveal if VUR is present. The process also improves patient care by diagnosing VUR at physicians offices instead of just at hospitals, significantly expanding the market and eliminating the risk that kidney damage occurs prior to the child being able to be diagnosed at a hospital.
